|
GPR125 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.342100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.192650E-01 |
| Normal-vs-Stage2 |
6.469800E-02 |
| Normal-vs-Stage3 |
1.765770E-04 |
| Normal-vs-Stage4 |
3.435200E-04 |
| Stage1-vs-Stage2 |
3.403200E-01 |
| Stage1-vs-Stage3 |
4.103400E-03 |
| Stage1-vs-Stage4 |
1.306410E-02 |
| Stage2-vs-Stage3 |
3.983000E-01 |
| Stage2-vs-Stage4 |
3.160800E-01 |
| Stage3-vs-Stage4 |
8.004600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.575100E-04 |
| Normal-vs-AfricanAmerican |
9.166600E-01 |
| Normal-vs-Asian |
3.621200E-01 |
| Caucasian-vs-AfricanAmerican |
1.059230E-01 |
| Caucasian-vs-Asian |
1.532620E-01 |
| AfricanAmerican-vs-Asian |
3.038000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.190000E-02 |
| Normal-vs-Female |
1.656710E-03 |
| Male-vs-Female |
2.215400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.191200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.383000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.401810E-02 |
| Normal-vs-Age(81-100Yrs) |
8.595100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.489400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.839800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.334600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.920800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.759700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.366300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.580400E-01 |
| Normal-vs-Grade 2 |
1.639640E-01 |
| Normal-vs-Grade 3 |
1.429550E-04 |
| Normal-vs-Grade 4 |
7.87939999999931E-05 |
| Grade 1-vs-Grade 2 |
4.567200E-01 |
| Grade 1-vs-Grade 3 |
2.264000E-01 |
| Grade 1-vs-Grade 4 |
1.516020E-01 |
| Grade 2-vs-Grade 3 |
5.858300E-03 |
| Grade 2-vs-Grade 4 |
2.197700E-03 |
| Grade 3-vs-Grade 4 |
2.163400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.039700E-03 |
| Normal-vs-ccB subtype |
1.678770E-01 |
| ccA subtype-vs-ccB subtype |
1.772410E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.576400E-04 |
| Normal-vs-N1 |
7.590400E-01 |
| N0-vs-N1 |
2.979600E-01 |
|
|
